Lorviqua | Description | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

25 mg: Round light pink immediate release film-coated tablet, debossed with "Pfizer" on one side and "25" and "LLN" on the other.
Each 25 mg film-coated tablet contains 25 mg of lorlatinib.
100 mg: Oval dark pink immediate release film-coated tablet, debossed with "Pfizer" on one side and "LLN 100" on the other.
Each 100 mg film-coated tablet contains 100 mg of lorlatinib.
Excipients/Inactive Ingredients: Tablet core contains: Microcrystalline cellulose, Calcium hydrogen phosphate, Sodium starch glycolate, Magnesium stearate.
Film-coating contains: Hypromellose, Lactose monohydrate, Macrogol, Triacetin, Titanium dioxide (E171), Iron oxide black (E172), Iron oxide red (E172).

Lorviqua Description

lorlatinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma